Search filters

List of works by Jessica J Lin

Clinical Acquired Resistance to KRAS<sup>G12C</sup> Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS-MAPK Reactivation

publication published on 06 April 2021

Landscape of Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired RET Fusion

scientific article published on 26 September 2018

MET Alterations are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer

scientific article published on 21 February 2020

Molecular Characterization and Therapeutic Targeting of Colorectal Cancers Harboring Receptor Tyrosine Kinase Fusions

scientific article published on 07 January 2021

Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor That Potently Inhibits ROS1/TRK/ALK Solvent- Front Mutations

scientific article published on 09 August 2018

Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer

scientific article published on 12 April 2018

Treatment with Next-Generation ALK Inhibitors Fuels Plasma ALK Mutation Diversity

scientific article published on 29 July 2019

Paulina is supported by:

About Paulina

Help